The interaction between no folic acid supplementation during early pregnancy and preeclampsia increased the risk of preterm birth

References

1. 1.↵
   1. Goldenberg RL,
   2. Culhane JF,
   3. Iams JD,
   4. Romero R.

   Epidemiology and causes of preterm birth. Lancet 2008; 371: 75–84.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Lawn JE,
   2. Cousens S,
   3. Zupan J.

   4 million neonatal deaths: when? Where? Why? Lancet 2005; 365: 891–900.

   OpenUrl
3. 3.↵
   1. Liu L,
   2. Oza S,
   3. Hogan D,
   4. Chu Y,
   5. Perin J,
   6. Zhu J, et al.

   Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet 2016; 388: 3027–3035.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Wu Y,
   2. Yuan Y,
   3. Kong C,
   4. Ma Q,
   5. Ye H,
   6. Jing W, et al.

   The association between periconceptional folic acid supplementation and the risk of preterm birth: a population-based retrospective cohort study of 200,000 women in China. Eur J Nutr 2021; 60: 2181–2192.

   OpenUrl
5. 5.
   1. Liu X,
   2. Lv L,
   3. Zhang H,
   4. Zhao N,
   5. Qiu J,
   6. He X, et al.

   Folic acid supplementation, dietary folate intake, and risk of preterm birth in China. Eur J Nutr 2016; 55: 1411–1422.

   OpenUrl
6. 6.
   1. Sharif ME,
   2. Mohamedain A,
   3. Ahmed AA,
   4. Nasr AM,
   5. Adam I.

   Folic acid level and preterm birth among Sudanese women. Matern Health Neonatol Perinatol 2017; 3: 25.

   OpenUrl
7. 7.↵
   1. Li B,
   2. Zhang X,
   3. Peng X,
   4. Zhang S,
   5. Wang X,
   6. Zhu C.

   Folic Acid and risk of preterm birth: a meta-analysis. Front Neurosci 2019; 13: 1284.

   OpenUrl
8. 8.↵
   1. Min Jiang, Miskatul Mustafa Mishu,
   2. Dan Lu,
   3. Xianghua Yin

   . A case control study of risk factors and neonatal outcomes of preterm birth. Taiwan J Obstet Gynecol 2018; 57: 814–818.

   OpenUrl
9. 9.↵
   1. Gejo NG,
   2. MT WM,
   3. Kebede BA,
   4. Abdo RA,
   5. Anshebo AA,
   6. Halil HM, et al.

   Factors associated with preterm birth at Wachemo University Nigist Eleni Mohammed memorial hospital, southern Ethiopia: case-control study. BMC Pregnancy Childbirth 2021; 21: 35.

   OpenUrl
10. 10.↵
    1. Knol MJ

    , VanderWeele TJ, Groenwold RHH, Klungel OH, Rovers MM, Grobbee DE. Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol 2011; 26: 433–438.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Zhang YJ,
    2. Shen J,
    3. Lin SB,
    4. Lu C,
    5. Jiang H,
    6. Sun Y, et al.

    The risk factors of preterm birth: A multicentre case-control survey in China in 2018. J Paediatr Child Health 2022; 58: 1396–1406.

    OpenUrl
12. 12.↵
    1. Xie X,
    2. Kong B,
    3. Duan T.

    Obstetrics and gynecology. 9th ed. Beijing: People’s Medical Publishing House. 2018.
13. 13.↵
    Hypertensive Disorders in Pregnancy Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association; Hypertensive Disorders in Pregnancy Subgroup Chinese Society of Obstetrics and Gynecology Chinese Medical Association. [Diagnosis and treatment of hypertension and pre-eclampsia in pregnancy: a clinical practice guideline in China (2020)]. Zhonghua Fu Chan Ke Za Zhi 2020; 55: 227–238.

    OpenUrl
14. 14.↵
    1. Obstetrics Subgroup

    , Chinese Society of Obstetrics and Gynecology, Chinese Medical Association; Group of Pregnancy with Diabetes Mellitus, Chinese Society of Perinatal Medicine, Chinese Medical Association, et al. [Diagnosis and therapy guideline of pregnancy with diabetes mellitus]. Zhonghua Fu Chan Ke Za Zhi 2014; 49:561–569. [in Chinese]

    OpenUrl
15. 15.↵
    World Health Organization. Guidelines for controlling and monitoring the tobacco epidemic. [Updated 1998]. Available from: https://apps.who.int/iris/handle/10665/42049
16. 16.↵
    1. Chen C,
    2. Lu FC

    , Department of Disease Control Ministry of Health, PR China. Guidelines for prevention and control of overweight and obesity in Chinese adults (excerpt). Biomed Environ Sci 2004; 25: 1–4.

    OpenUrl
17. 17.↵
    1. Chuce Dai, Yiming Fei,
    2. Jianming Li, Yang Shi,
    3. Xiuhua Yang

    . A novel review of homocysteine and pregnancy complications. Biomed Res Int 2021; 2021: 6652231.

    OpenUrl
18. 18.↵
    1. Weronika Dymara-Konopka,
    2. Marzena Laskowska

    . The role of nitric oxide, ADMA, and homocysteine in The etiopathogenesis of preeclampsia-review. Int J Mol Sci 2019; 20: 2757.

    OpenUrl
19. 19.↵
    1. Mekuriyaw AM,
    2. Mihret MS,
    3. Yismaw AE.

    Determinants of preterm birth among women who gave birth in Amhara Region Referral hospitals, Northern Ethiopia, 2018: institutional based case control study. Int J Pediatr 2020; 2020: 1854073.
20. 20.↵
    1. E L,
    2. Zhang C,
    3. Wang G,
    4. Ma Z

    . Investigation on the incidence, risk factors and pregnancy outcomes of pregnancy-induced hypertension in Xining area from 2007-2016. Matern Child Health J 2018; 33: 642–644. [in Chinese]

    OpenUrl
21. 21.↵
    1. Deng L,
    2. Fang B.

    Clinical epidemiological analysis of pregnancy-induced hypertension. Hainan Medical Journal 2015; 26: 2602–2603. [in Chinese]

    OpenUrl
22. 22.↵
    1. Shao Y,
    2. Qiu W,
    3. Mao B,
    4. Li Y,
    5. Zhou M,
    6. Yang L, et al.

    Correlation between folic acid intake before and during pregnancy and preterm birth. Matern Child Health J 2017; 32: 575–578. [in Chinese]

    OpenUrl